Chemically engineered peptides could help fight persistent human health challenges

Reviewed by Emily Henderson, B.Sc.Jun 26 2020 Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human...

UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug

A cannabinoid medication marketed by GW Pharmaceuticals for the treatment of severe forms of epilepsy will be more easily available to patients in the UK after the drug was moved to the least strict...

Engineering the Immune Response for Therapeutic Success

In the first of the articles included in this eBook, Carl June describes the development of CAR T cells as “a long and winding road.” This and other selected articles indicate why this is...

Packaging and Producer Cell Lines for Scalable Lentiviral Production

/* custom css */ .td_uid_1_5ef82399022b3_rand { min-height: 0; } /* custom css */ .td_uid_2_5ef82399024f3_rand { vertical-align: baseline; } REGISTER NOW jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5ef82399022ac .td-element-style').each(function (index, element) { jQuery(element).css('opacity', 1); return; }); }); ...

CSL Behring Nabs UniQure’s Hemophilia Gene Therapy for up to €1.8B

Big pharma CSL Behring will pay the Dutch gene therapy developer uniQure an upfront of €400M for the global rights to a phase III-stage gene therapy for the blood disorder hemophilia B. Under the terms...

Researchers Discover Why ApoE4 Increases the Risk of Alzheimer’s Disease

Apolipoproteins (Apos) are proteins that transport lipids by binding to them. They also can act as enzyme co-factors and cell-surface receptor ligands. Without proper function of apolipoproteins in the body, a variety of disorders...

Investing in the vaccines of tomorrow: the case for biotechnology – Livewire Markets

Technology may typically be thought of in terms of computers and communications but its use in the sphere of biotechnology is saving lives and changing how we treat diseases. While investing in this area...

Entos Pharmaceuticals selects two lead DNA vaccine candidates for COVID-19

Reviewed by Emily Henderson, B.Sc.Jun 25 2020 Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus...

First comparison of dangers of tobacco cigarettes, e-cigarettes and waterpipes

Any smoking and vaping technique may increase risk of COVID-19 infection and death Credit: European Heart Journal Smoking and vaping, whether by means of tobacco cigarettes, e-cigarettes or...

Mitigating Viral Contamination, a Challenge for Emerging Therapies

Mitigating the risk of viral contamination poses a challenge to companies manufacturing new cell and gene therapies. That’s one conclusion of what is believed to be the first industry-wide study into viral contamination events in...